Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Its gastrointestinal side-effect burden is dose-dependent and comparable to the rest of the GLP-1 class, not lighter
Hims offers a branded Zepbound pathway through Lilly's direct programs
Tirzepatide (Mounjaro, Zepbound) activates two: GLP-1 and GIP
Advise patients using oral hormonal contraceptives to switch to a non-oral contraceptive method or add a barrier method of contraception for 4 weeks after initiation and for 4 weeks after each dose escalation with MOUNJARO [see Drug Interactions (7.2), Use in Specific Populations (8.3), and Clinical Pharmacology (12.3)]
Pharmacol Res Perspect 9(3):e00750
Korner, M., Waser, B
US$ 26.94
US$ 29.67
US$ 22.20
